
It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

